{"id":"NCT05027308","sponsor":"Takeda","briefTitle":"A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or Older","officialTitle":"A Phase 3, Open-label Safety Study of Teduglutide in Japanese Pediatric Patients With Short Bowel Syndrome Who Are Dependent on Parenteral Support, Aged 4 Months of Corrected Gestational Age or Older, and Requiring the Dosing of 1.25 mg Formulation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-01-04","primaryCompletion":"2023-09-27","completion":"2023-09-27","firstPosted":"2021-08-30","resultsPosted":"2024-05-16","lastUpdate":"2024-05-16"},"enrollment":3,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Short Bowel Syndrome"],"interventions":[{"type":"DRUG","name":"Teduglutide","otherNames":["TAK-633"]}],"arms":[{"label":"Teduglutide 0.05 milligram per kilogram (mg/kg)","type":"EXPERIMENTAL"}],"summary":"The main aims of the study are to check for side effects from teduglutide.\n\nParticipants will receive a daily injection of teduglutide just under the skin (subcutaneous) for 24 weeks. Then they are followed up for another 4 weeks. Participants may be able to repeat this treatment if they meet specific criteria. The study doctors will check for side effects from teduglutide until it becomes commercially available. The maximum duration of treatment is approximately 51.3 weeks.","primaryOutcome":{"measure":"Number of Participants With Treatment-emergent Adverse Events (TEAEs)","timeFrame":"From first dose of study drug until follow-up visit (4 weeks after end of treatment [EOT]/end of termination [ET] {up to 47.3-51.3 weeks})","effectByArm":[{"arm":"Teduglutide","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":6,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":["https://clinicaltrials.takeda.com/study-detail/613b9c47c61629002b6311f0"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":3},"commonTop":["COVID-19","Enterocolitis","Respiratory syncytial virus infection","Blood iron increased","Catheter site rash"]}}